Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Authorities arrest 7 bodyguards in connection with a Mexican mayor's assassination - 2Beating Wellbeing Difficulties: Individual Victories in Health
- 3Investigating Free Cell Phones: What You Really want to Be aware
- 4From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
- 54 Famous Attractions at Disneyland
- Netanyahu vows to ‘return Negev to Israel,’ pledges settlement growth during visit
- Cocoa Prices Sink on Favorable Crop Conditions in West Africa
- 10 Hints for a Fruitful New employee screening
- A Manual for Extravagant Vehicles Available in 2024
- ISS astronaut evacuation shouldn't interfere with upcoming Artemis 2 moon mission, NASA chief says
- Flu concerns grow in US as UK sees more cases among kids
- Far-right leader Le Pen to attend Brigitte Bardot's funeral
- Trump signs a law returning whole milk to school lunches
- Private sector revives the climate disaster database Trump tried to squash
